AI in Medicine is at the forefront of integrating artificial intelligence with healthcare solutions. We are dedicated to developing cutting-edge AI-powered tools that enhance diagnostic accuracy, accelerate drug discovery pipelines, personalize patient treatment plans, and improve overall healthcare efficiency. Our mission is to empower medical professionals and researchers with intelligent systems to solve complex medical challenges and improve patient outcomes globally.
Serves as the central hub for research and development, corporate strategy, business development, and administrative operations. Key AI model development and clinical trial collaborations are managed from here.
State-of-the-art AI research labs, collaborative open-plan workspaces designed to foster innovation, and a dedicated data center for high-performance computing.
A dynamic, collaborative, and mission-driven environment. Employees are encouraged to be innovative, take initiative, and contribute to a culture of continuous learning and ethical AI development. Emphasis on work-life balance and cross-functional teamwork.
The Cambridge location provides unparalleled access to world-class research institutions like MIT and Harvard, leading hospitals, and a rich ecosystem of biotech and tech companies, fostering collaboration and talent acquisition.
AI in Medicine supports global operations through its headquarters in Cambridge, MA, and its European office in Berlin. Key functions supported globally include advanced AI research, software development, clinical validation partnerships, international sales and marketing, customer implementation, and technical support for its AI-powered healthcare platforms.
101 Main Street, Suite 500
Cambridge
MA
USA
Address: Friedrichstraße 100, 10117 Berlin
Serves as the primary hub for sales, customer support, and R&D collaborations within the European Union, adapting AI solutions to meet regional healthcare standards and needs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AIMed' leadership includes:
AIMed has been backed by several prominent investors over the years, including:
In the past year, AI in Medicine has strengthened its leadership team with a key appointment to drive operational excellence. There have been no executive departures in this period.
Discover the tools AIMed uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
AI in Medicine primarily uses the [first_initial][last_name]@[domain] (e.g., ereed@ai-in-medicine-corp.com) or [first_name].[last_name]@[domain] (e.g., evelyn.reed@ai-in-medicine-corp.com) email formats. The first initial last name format is common.
flast@ai-in-medicine-corp.com or first.last@ai-in-medicine-corp.com
Format
ereed@ai-in-medicine-corp.com
Example
85%
Success rate
TechHealth Today • March 15, 2024
AI in Medicine announced today the successful closure of a $50 million Series B funding round led by Global Health Innovators Fund, with participation from existing investors TechBio Ventures and Kendall Square Capital Partners. The new capital will be used to accelerate the development and commercialization of its flagship AI platform for early cancer detection and expand its research into AI applications for rare diseases....more
Global AI Healthcare News • January 22, 2024
AI in Medicine's novel AI algorithm for predicting ischemic stroke risk has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This designation will expedite the development and review process for the technology, which aims to provide clinicians with an early warning system for high-risk patients....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AIMed, are just a search away.